Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04869137
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2021-04-28
Brief Title:
Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma
Sponsor:
Organization:
H Lee Moffitt Cancer Center and Research Institute